United StatesBreaking News

Alan Greenspan has died at the age of 100. Greenspan's 18 years as Fed chief, from 1987 until his retirement at the start of 2006, were marked by a stock market boom and low unemployment. Bloomberg's Michael McKee reports on how Wall Street may see Greenspan's legacy.

US Vice President JD Vance said talks with Iran over the weekend were "very, very good," as the sides attempt to reach a peace deal within two months and formally end a war. Vance says a key point was building a mechanism to keep the Strait of Hormuz open. He spoke to reporters in Emmen, Switzerland where talks are being held.

HII (NYSE:HII) announced today that its Mission Technologies division has received a $418 million, five-year indefinite delivery/indefinite quantity (IDIQ) contract to support U.S. Navy fleet operational readiness.

Eli Lilly (NYSE:LLY) announced that its board of directors has declared a cash dividend of $1.73 per share on outstanding common stock for the third quarter of 2026.

Mackenzie Investments chief investment officer Lesley Marks and Morgan Stanley private wealth advisor and senior portfolio manager Katerina Simonetti discusses the US and Iran nuclear talks, their market outlook following the SpaceX IPO. They spoke with Guy Johnson on June 19, 2026.

Upside Co-Founder and CEO Alex Kinnier joins Bloomberg Open Interest to explain why American consumers are feeling squeezed despite falling gas prices, reveals what transaction data says about spending habits. He also discusses how AI is transforming retail with hyper-personalized offers that save consumers money while helping retailers grow profits.

Wall Street traders drove stocks down from the brink of all-time highs as a renewed slide in SpaceX overshadowed optimism about progress in peace talks between the US and Iran. Mamadou-Abou Sarr, President & Co-Founder of V-Square Quantitative Management discusses the markets and how he is encouraging diversified investing.

On this episode of Stock Movers with Nathan Hager: - Apogee (APGE) shares are soaring on news AbbVie is closing in on a nearly $11 billion deal to buy inflammatory disease drug developer Apogee Therapeutics. That's also according to a Financial Times report. - Regenxbio (RGNX) shares are moving on news Regenxbio aligned with the FDA on next steps for a potential accelerated approval of Navsunli, a gene therapy for Mucopolysaccharidosis II, with the FDA confirming the company doesn't need to conduct additional studies of the drug. - SpaceX (SPCX) is lower this morning, continuing its slide after its record IPO.

Alamos Gold CEO John McCluskey joins Bloomberg Open Interest to explain the seismic disruption behind the company's production cut, why he sees the setback as temporary, and why he rejects the idea that a weaker share price makes Alamos an M&A target.

Former Fed Governor Randy Kroszner joined Bloomberg Open Interest to break down Alan Greenspan's complicated legacy crediting him for fueling America's economic boom while acknowledging the risks that helped lead to the 2008 financial crisis. He also explains why the next era of the Federal Reserve could feature simpler communication and a renewed focus on long-term economic trends.

SpaceX (NASDAQ:SPCX) has initiated its first-ever bond sale to repay outstanding debt following a 7% decline in its share price during early Monday trade.

Republican Senator Dave McCormick of Pennsylvania joins "Bloomberg Surveillance" to discuss the current state of negotiations with Iran, the death of Alan Greenspan and how the Federal Reserve will operate under its new Chairman Kevin Warsh.